LPL Financial’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Buy |
|
|||||
|
2025
Q1 | $209K | Sell |
|
|||||
|
2024
Q4 | $312K | Buy |
|
|||||
|
2024
Q3 | $358K | Buy |
|
|||||
|
2024
Q2 | $321K | Sell |
|
|||||
|
2024
Q1 | $420K | Sell |
|
|||||
|
2023
Q4 | $357K | Sell |
|
|||||
|
2023
Q3 | $324K | Sell |
|
|||||
|
2023
Q2 | $411K | Sell |
|
|||||
|
2023
Q1 | $412K | Sell |
|
|||||
|
2022
Q4 | $508K | Sell |
|
|||||
|
2022
Q3 | $510K | Sell |
|
|||||
|
2022
Q2 | $481K | Sell |
|
|||||
|
2022
Q1 | $1.06M | Sell |
|
|||||
|
2021
Q4 | $1.77M | Buy |
|
|||||
|
2021
Q3 | $2.02M | Buy |
|
|||||
|
2021
Q2 | $1.99M | Buy |
|
|||||
|
2021
Q1 | $2.02M | Buy |
|
|||||
|
2020
Q4 | $1.91M | Buy |
|
|||||
|
2020
Q3 | $1.41M | Sell |
|
|||||
|
2020
Q2 | $1.83M | Buy |
|
|||||
|
2020
Q1 | $857K | Buy |
|
|||||
|
2019
Q4 | $842K | Sell |
|
|||||
|
2019
Q3 | $651K | Sell |
|
|||||
|
2019
Q2 | $1.28M | Buy |
|
|||||
|
2019
Q1 | $911K | Buy |
|
|||||
|
2018
Q4 | $708K | Sell |
|
|||||
|
2018
Q3 | $1.36M | Sell |
|
|||||
|
2018
Q2 | $1.36M | Buy |
|
|||||
|
2018
Q1 | $1.3M | Buy |
|
|||||
|
2017
Q4 | $924K | Sell |
|
|||||
|
2017
Q3 | $962K | Buy |
|
|||||
|
2017
Q2 | $366K | Sell |
|
|||||
|
2017
Q1 | $690K | Buy |
|
|||||
|
2016
Q4 | $325K | Sell |
|
|||||
|
2016
Q3 | $425K | Sell |
|
|||||
|
2016
Q2 | $446K | Sell |
|
|||||
|
2016
Q1 | $940K | Buy |
|
|||||
|
2015
Q4 | $769K | Buy |
|
|||||
|
2015
Q3 | $389K | Sell |
|
|||||
|
2015
Q2 | $897K | Buy |
|
|||||
|
2015
Q1 | $624K | Buy |
|